The Society of Hematologic Oncology (SOHO) has announced an exclusive live session, “Practical Strategies for Optimizing Outcomes in MDS and AML,” to be held on Tuesday, September 8, 2026, at the George R. Brown Convention Center in Houston, Texas, ahead of the SOHO 2026 Annual Meeting. The session will begin at 3 pm and will be chaired by Guillermo Garcia-Manero, MD, of the University of Texas MD Anderson Cancer Center. Registration is now open.
Designed as a case-based, interactive program, the session will provide practical strategies and clinical insights to help clinicians integrate the latest advances in the management of myelodysplastic syndromes and acute myeloid leukemia into everyday practice. The session will feature Sangeetha Venugopal, MD, MS, of Sylvester Comprehensive Cancer Center; Rami S. Komrokji, MD, of H. Lee Moffitt Cancer Center; Naval Daver, MD, of MD Anderson Cancer Center; and Courtney D. DiNardo, MD, MSCE, of MD Anderson Cancer Center. For a full list of speakers and sessions, scroll down.
Registration information
To participate in this exclusive session, attendees must be registered for the SOHO 2026 Annual Meeting. Visit soho.click/register to complete your SOHO 2026 registration and select the “Practical Strategies for Optimizing Outcomes in MDS and AML” session. Registrants who have already registered for SOHO 2026 can edit their cart to add the Tuesday program.
Program
Myelodysplastic syndromes
Chair: Guillermo Garcia-Manero, MD
| Time | Session | Speaker |
|---|---|---|
| 3:00 – 3:05 p.m. | Welcome and Introduction | Guillermo Garcia-Manero, MD |
| 3:05 – 3:15 p.m. | Changing Treatment Goals in Low-Risk MDS | Sangeetha Venugopal, MD, MS |
| 3:15 – 3:25 p.m. | Post-HMA Treatment Options in High-Risk MDS | Rami S. Komrokji, MD |
| 3:25 – 3:35 p.m. | Targeted Therapies in Low-Risk MDS | Kelly S. Chien, MD |
| 3:35 – 3:45 p.m. | Treatment of Higher-Risk MDS | Guillermo Garcia-Manero, MD |
3:45 – 4:00 pm Post-Assessment Polling Questions, Q&A, and Break
Acute myeloid leukemia
| Time | Session | Speaker |
|---|---|---|
| 4:00 – 4:05 p.m. | Introduction and Pre-Assessment Polling | Naval Daver, MD |
| 4:05 – 4:15 p.m. | Choosing the Right Induction Therapy: Debate PRO | Amir Fathi, MD |
| 4:15 – 4:25 p.m. | Choosing the Right Induction Therapy: Debate CON | Courtney D. DiNardo, MD, MSCE |
| 4:25 – 4:35 p.m. | Frontline Mutation-Directed & Mutation-Agnostic Triplet Therapy | Naval Daver, MD |
| 4:35 – 4:45 p.m. | Evolving Transplant Eligibility & Optimal Conditioning/Maintenance | TBA |
| 4:45 – 4:55 p.m. | MRD Assessment Technologies & Interventions | Andrew Wei, MBBS, PhD |
4:55 – 5:05 pm Post-Assessment Polling Questions, Q&A, and Adjourn
